Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -62.75%44.97M | -1.84%189.04M | 237.55%120.74M | -13.74%192.57M | -38.07%78.61M | -60.18%35.77M | -57.34%12.6M | 30.03%223.24M | 2.79%126.94M | 20.21%89.84M |
| Operating income | -62.75%44.97M | -1.84%189.04M | 237.55%120.74M | -13.74%192.57M | -38.07%78.61M | -60.18%35.77M | -57.34%12.6M | 30.03%223.24M | 2.79%126.94M | 20.21%89.84M |
| Cost of sales | 65.78%-28.43M | 11.42%-123.05M | -244.63%-83.08M | 28.91%-138.91M | 55.39%-49.99M | 69.85%-24.11M | 64.12%-10.24M | -41.74%-195.41M | -19.59%-112.06M | -48.10%-79.96M |
| Operating expenses | 65.78%-28.43M | 11.42%-123.05M | -244.63%-83.08M | 28.91%-138.91M | 55.39%-49.99M | 69.85%-24.11M | 64.12%-10.24M | -41.74%-195.41M | -19.59%-112.06M | -48.10%-79.96M |
| Gross profit | -56.06%16.55M | 22.97%65.98M | 222.90%37.66M | 92.81%53.66M | 92.33%28.62M | 18.10%11.66M | 135.83%2.36M | -17.70%27.83M | -50.05%14.88M | -52.40%9.88M |
| Selling expenses | 66.62%-959K | -60.26%-8.29M | -19.01%-2.87M | 19.65%-5.17M | 26.12%-3.56M | 30.73%-2.41M | 49.34%-1.07M | 15.24%-6.44M | 10.02%-4.82M | -9.04%-3.49M |
| Administrative expenses | 4.09%-48.76M | 0.79%-121.58M | 14.66%-50.83M | -27.58%-122.55M | -65.41%-108.11M | -33.78%-59.56M | -51.15%-32.72M | 9.62%-96.06M | 30.80%-65.36M | 9.74%-44.52M |
| Profit from asset sales | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -106.68%-3.69M | -101.80%-1.43M | ---1.7M |
| Revaluation surplus | -1,099.65%-5.74M | 145.61%2.85M | 128.83%574K | -111.62%-6.25M | -173.65%-1.97M | -173.31%-1.99M | ---- | 2,114.57%53.77M | 552.97%2.67M | 561.90%2.72M |
| -Changes in the fair value of investment property | -1,099.65%-5.74M | 145.61%2.85M | 128.83%574K | -111.62%-6.25M | -173.65%-1.97M | -173.31%-1.99M | ---- | 2,114.57%53.77M | 552.97%2.67M | 561.90%2.72M |
| Impairment and provision | ---- | 29.01%-33.34M | ---- | 64.81%-46.96M | 205.57%22.59M | 205.57%22.59M | ---- | -125.91%-133.44M | ---21.4M | ---21.4M |
| -Other impairment is provision | ---- | 29.01%-33.34M | ---- | 64.81%-46.96M | 205.57%22.59M | 205.57%22.59M | ---- | -125.91%-133.44M | ---21.4M | ---21.4M |
| Special items of operating profit | -84.56%10.62M | 1,111.56%37.7M | 161.45%68.79M | 96.33%-3.73M | 174.78%39.65M | 158.60%26.31M | 1,334.75%48.82M | -28.88%-101.68M | -152.98%-53.01M | -36.39%-44.9M |
| Operating profit | -153.05%-28.29M | 56.74%-56.68M | 1,666.74%53.32M | 49.56%-131.01M | 82.27%-22.77M | 96.71%-3.4M | 165.15%17.4M | -57.02%-259.71M | -955.72%-128.47M | -58.40%-103.42M |
| Financing cost | 40.63%-171K | 7.58%-549K | 11.11%-288K | 74.72%-594K | 71.38%-469K | 73.62%-324K | 72.68%-174K | 34.94%-2.35M | 36.45%-1.64M | 31.47%-1.23M |
| Share of profits of associates | -271.58%-1.44M | -157.23%-836K | ---387K | ---325K | ---72K | ---- | ---- | ---- | ---- | ---- |
| Earning before tax | -156.79%-29.89M | 55.99%-58.06M | 1,512.42%52.64M | 49.66%-131.92M | 82.08%-23.31M | 96.44%-3.73M | 162.99%17.22M | -55.06%-262.06M | -782.21%-130.11M | -55.99%-104.64M |
| Tax | -15.79%-176K | -126.98%-3.96M | 88.89%-152K | 150.56%14.66M | -10.15%-1.5M | -10.14%-1.37M | 11.69%-831K | -615.92%-29M | 70.10%-1.36M | 56.27%-1.24M |
| After-tax profit from continuing operations | -157.29%-30.07M | 47.11%-62.02M | 1,130.21%52.49M | 59.71%-117.26M | 81.13%-24.81M | 95.19%-5.1M | 157.96%16.39M | -68.19%-291.07M | -581.33%-131.47M | -51.44%-105.89M |
| Earning after tax | -157.29%-30.07M | 47.11%-62.02M | 1,130.21%52.49M | 59.71%-117.26M | 81.13%-24.81M | 95.19%-5.1M | 157.96%16.39M | -68.19%-291.07M | -581.33%-131.47M | -51.44%-105.89M |
| Minority profit | 88.32%-78K | 98.72%-46K | -13.80%-668K | -280.78%-3.61M | -24.46%-804K | -14.42%-587K | -356.25%-365K | -67.31%-947K | -118.24%-646K | -111.98%-513K |
| Profit attributable to shareholders | -156.42%-29.99M | 45.47%-61.97M | 1,279.17%53.16M | 60.82%-113.65M | 81.65%-24.01M | 95.72%-4.51M | 159.42%16.76M | -68.19%-290.12M | -588.54%-130.82M | -51.22%-105.37M |
| Basic earnings per share | -156.54%-0.0121 | 60.00%-0.02 | 1,288.89%0.0214 | 58.33%-0.05 | 81.56%-0.0097 | 95.75%-0.0018 | 159.29%0.0067 | -71.43%-0.12 | -583.12%-0.0526 | -49.82%-0.0424 |
| Diluted earnings per share | -156.54%-0.0121 | 60.00%-0.02 | 1,288.89%0.0214 | 58.33%-0.05 | 81.56%-0.0097 | 95.75%-0.0018 | 159.29%0.0067 | -71.43%-0.12 | -583.12%-0.0526 | -49.82%-0.0424 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | -- | -- | Furimazer Certified Public Accountants Limited | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.